Thomson Reuters (TRI)
(Delayed Data from NYSE)
$167.78 USD
-0.09 (-0.05%)
Updated May 10, 2024 04:00 PM ET
After-Market: $167.77 -0.01 (-0.01%) 7:58 PM ET
3-Hold of 5 3
D Value C Growth C Momentum D VGM
Price, Consensus and EPS Surprise
TRI 167.78 -0.09(-0.05%)
Will TRI be a Portfolio Killer in May?
Zacks Investment Research is releasing its prediction for TRI based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for TRI
Thomson Reuters (TRI) Reports Q1 Earnings: What Key Metrics Have to Say
Thomson Reuters (TRI) Beats Q1 Earnings and Revenue Estimates
TRI: What are Zacks experts saying now?
Zacks Private Portfolio Services
Should You Buy Thomson Reuters (TRI) Ahead of Earnings?
Ahead of Thomson Reuters (TRI) Q1 Earnings: Get Ready With Wall Street Estimates for Key Metrics
Thomson Reuters (TRI) Reports Next Week: Wall Street Expects Earnings Growth
Other News for TRI
Dividend Champion, Contender, And Challenger Highlights: Week Of May 12
Trivarx Limited Expands Portfolio with New Shares
Trivarx Limited Issues 10M Unlisted Options
Trivarx Limited Announces New ASX Securities
Trivarx Limited Applies for New Stock Quotation